1Makrydimas G,Sotiriadis A,Loannidis JP.Screening performance of first-trimester nuchal translucency for major eardiac defects a meta-analysis[J].Am J Obstet Gyneeol,2003,189:1330-1335.
2Von Kaisenberg CS,Krenn V,Ludwig M,et al.Morphological classification of nuchal skin in futuses with trisomy-21.18 and 13 at 12～18 weeks and in a trisomy 16 mouse[J].Anat Embryol,1998,197:105-124.
3Sebire NJ,Bianco D,Snuders RJM,et al.Increased fetal nuchal translucency thinkness at 10～14 wceks is screening for maternal fetal infection necessary?[J].Br J Obstet Gynaecol,1997,104:212-215.
5Isakros J. Outcome of nonimmune hydrops fetalis diagnosed during the first haif of pregnancy [J]. Obstetrcs any Gynecolgy, 1997, 3: 321-325.
6Nicolaides KH, Cheng HH, Abbas A, et al. Fetal renal defects: Associated malformations and chron~omat det~~'ts [J]. Fetal Diagn Ther, 1992, 7(1): 1-11.
7Said S. Mahme FD. The use o1" nut'hal translucency in conlem porary obstetric practice [J]. Clin Obstel Gynecohn. 2008. 51(1): 37.
8Ginsberg N, Cadkin A. Pergamenl E, et al. Uhrasonogralfllic de- tection of the second-trimester fetus wilh trisomv 18 and trisomy 21[J]. Am J Obstet Gyneco, 1990, 163(4 pt 1): 1186-1190.
